Cargando…
Intermediate between Idiopathic Hypereosinophilia and Chronic Eosinophilic Leukemia: A Report of Two Hypereosinophilic Cases with Possible Novel Molecular Mutations
To distinguish a reactive eosinophilia from its malignant counterpart is challenging. Establishing clonality of the eosinophils is crucial and considered the determining factor for establishing a diagnosis. Cases of hypereosinophilia without clear reactive etiologies, no evidence of end-organ damage...
Autores principales: | Choudhuri, Jui, Eskandari, Mohammad, Shi, Yang, Wang, Yanhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426067/ https://www.ncbi.nlm.nih.gov/pubmed/34513100 http://dx.doi.org/10.1155/2021/1142124 |
Ejemplares similares
-
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes
por: Stella, Stefania, et al.
Publicado: (2021) -
Current Concepts on the Pathogenesis of the Hypereosinophilic Syndrome/Chronic Eosinophilic Leukemia
por: Yamada, Yoshiyuki, et al.
Publicado: (2006) -
Eosinophilic myocarditis and hypereosinophilic syndrome
por: Boussir, Hanane, et al.
Publicado: (2017) -
Hypereosinophilic Syndrome With Eosinophilic Gastritis
por: Nayak, Vignesh Hebri, et al.
Publicado: (2017) -
Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome
Publicado: (1989)